All News

The painful physical symptoms of depression often go unrecognized and/or untreated, although 69% of those with the condition list physical symptoms as the main reason for a visit to their primary care physician. Fortunately, clinicians can now offer patients with depression an agent that addresses both depressed mood and common physical symptoms, such as back pain. The FDA recently approved duloxetine (Cymbalta, Eli Lilly) capsules for the treatment of Major Depressive Disorder. The drug is currently available in pharmacies.

The Department of Health & Human Services unveiled proposed regulations governing the Medicare Part D prescription drug benefit slated to debut in January 2006.

Combination products make treatment regimens for HIV/AIDS easier to follow, because such regimens often require the simultaneous use of 3 or more drugs from different classes. The FDA recently approved abacavir/lamivudine (Epzicom, GlaxoSmithKline) 600 mg/300 mg tablets for the treatment of HIV infection. The drug will be available in U.S. pharmacies by the end of August or in early September.

Medicare Rx discount cards save beneficiaries money but the prices offered by the cards vary widely, according to an analysis conducted for the Kaiser Family Foundation.

Canadian mail order pharmacies filling prescriptions for Wisconsin residents are violating the conditions set by the governor, according to on-going analysis by the Pharmacy Society of Wisconsin.

Groups representing independent pharmacies and their nemesis, pharmacy benefit managers, are waging a public relations war to win the hearts and minds of legislators and employers.